• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CM1
Click for more information
0.00% 5.2¢

COOLGARDIE MINERALS LIMITED - Corporate Spotlight

Currently unlisted. Proposed listing date: 30 AUGUST 2018, 12:30 PM AEST ## watchlist Created with Sketch. Add to my watchlist

Coolgardie Minerals Limited is an Australia-based gold exploration company. The Company’s... Coolgardie Minerals Limited is an Australia-based gold exploration company. The Company’s principal project is the Bullabulling Gold Project (BGP) located in Western Australia. The BGP covers an area of about 475 square kilometers. Through the BGP, the Company has identified gold exploration prospects that include Geko Gold Open Pit Project, First Find, Endeavour, Bungarra, Ubini, Chuckwalla, Komodo-Mallee Dragon Trend, Goanna, West Endeavour and Shooters. The BGP also consists of Lithium and Nickel prospects. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

Top Stories

Market Update: Energy keeps light bright in a sea of red

The ASX is down .7 of a per cent with every sector - except energy - in the red and real estate diving nearly 2 per cent mid-session.
Chariots of fire on pole to meet resurgent US lithium security focus. Chariot Corporation is a company in a hurry.Since listing on the Australian stock exchange (ASX) in October, Chariot’s focus has been on building up a significant suite of lithium projects across three US states with the goal of securing future supply of the mineral to fulfil a vo...
Canada's Hillcrest Energy (CSE.HEAT) partners with BC's Powertech Labs Canada-based Hillcrest Energy Technologies has teamed up with British Columbia-based Powertech Labs to test Hillcrest's ZVS technology.
Week 15 Wrap: USA uncertain, ECB shrugs at the Fed & gold, gold, gold Depending on what interests you more, there were two big stories this week for the international finance space.
Recce Pharmaceuticals up 6% on new antibiotic production milestone Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.